Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Acoltremon in Stage I Neurotrophic Keratopathy
NCT07502378Phase 4Recruiting
- Sponsor
- University of South Florida
- Start
- Apr 2026
- Primary completion
- Mar 2027
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of acoltremon in neurotrophic keratopathy (NK), sponsored by University of South Florida. Started Apr 2026; status: recruiting.
02
Drugs
acoltremon
03
Conditions
neurotrophic keratopathy (NK)
Beyond the preview
Go deeper on NCT07502378.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07502378.